Biliverdin reductase-A protein levels and activity in the brains of subjects with Alzheimer disease and mild cognitive impairment

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

卷:1812

Article

Barone, Eugenio^1,2,3  Di Domenico, Fabio^1,2,4  Cenini, Giovanna^1,2  Sultana, Rukhsana^1,2  Cini, Chiara⁴  Preziosi, Paolo³  Perluigi, Marzia⁴  Mancuso, Cesare³  Butterfield, D. Allan^1,2 

[1] Univ Kentucky, Ctr Membrane Sci, Dept Chem, Lexington, KY 40506 USA

[2] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40506 USA

[3] Univ Cattolica Sacro Cuore, Inst Pharmacol, Sch Med, I-00168 Rome, Italy

[4] Univ Roma La Sapienza, Dept Biochem Sci, I-00185 Rome, Italy

关键词: Alzheimer disease;    Biliverdin reductase;    Cerebellum;    Hippocampus;    Mild cognitive impairment;    Oxidative stress;   

DOI  :  10.1016/j.bbadis.2011.01.005

来源: Elsevier

【 摘 要 】

Biliverdin reductase-A is a pleiotropic enzyme involved not only in the reduction of biliverdin-IX-alpha into bilirubin-IX-alpha, but also in the regulation of glucose metabolism and cell growth secondary to its serine/threonine/tyrosine kinase activity. Together with heme oxygenase, whose metabolic role is to degrade heme into biliverdin-IX-alpha, it forms a powerful system involved in the cell stress response during neurodegenerative disorders. In this paper, an up-regulation of the biliverdin reductase-A protein levels was found in the hippocampus of the subjects with Alzheimer disease and arguably its earliest form, mild cognitive impairment. Moreover a significant reduction in the phosphorylation of serine, threonine and tyrosine residues of biliverdin reductase-A was found, and this was paralleled by a marked reduction in its reductase activity. Interestingly, the levels of both total and phosphorylated biliverdin reductase-A were unchanged as well as its enzymatic activity in the cerebella. These results demonstrated a dichotomy between biliverdin reductase-A protein levels and activity in the hippocampus of subjects affected by Alzheimer disease and mild cognitive impairment, and this effect likely is attributable to a reduction in the phosphorylation of serine, threonine and tyrosine residues of biliverdin reductase-A. Consequently, not just the increased levels of biliverdin reductase-A, but also its changed activity and phosphorylation state, should be taken into account when considering potential biomarkers for Alzheimer disease and mild cognitive impairment. (C) 2011 Elsevier B.V. All rights reserved.

【 授权许可】

Free